AMI Research Stock Reports

AMI Research Press Releases

Cancer Genetic Testing Lab Raises FY ’07 Guidance, Announces Growth Initiatives

Key Largo, FL, January 19, 2007 -- The American Microcap Institute (AMI), a leading online resource for microcap investors and a division of Hawk Associates Inc., announced today that it issued an update to its analyst coverage on NeoGenomics, Inc. (OTC Bulletin Board: NGNM) based on the company’s third quarter earnings.

NeoGenomics is an independent medical laboratory company specializing in genetic testing for cancer. AMI maintained its “strong buy” rating and set a price target range of $1.80 to $2.10 by the end of 2007. The third quarter of 2006 was NeoGenomics’ third consecutive profitable quarter. Total revenues grew 186% year-over-year but decreased 9% on a sequential basis due to seasonality and a transition in customer base to higher margin clients. The company also announced a record number of new customers in Q3, the opening of a new lab in Irvine, Calif., and the introduction of a new genetic pathology solutions (GPS) testing service. Subsequent to the release of Q3 earnings, NeoGenomics also announced the launch of the industry’s first tech-only FISH testing service for pathologists.

The third quarter analyst update and previous reports on the company can be accessed for free on the AMI Research website, http://www.amistockreports.com.

About AMI Research
AMI Research, a service of the American Microcap Institute, provides fundamental research on promising small companies that do not have traditional Wall Street analyst coverage. These detailed issuer-paid research reports provide investors with an in-depth understanding of a company and its technology, industry, business model, financials and growth prospects.

AMI Research does not accept payment of fees in company stock. Principals and analysts are prohibited from owning or trading in securities of covered companies. The views expressed in AMI reports accurately reflect the analyst's personal views about the subject securities or issuer. Neither the analyst's compensation nor the compensation received by the company is in any way related to the specific ratings or views contained in the report. Please read all disclosures and certifications in each report prior to investing. For more information, visit http://www.amistockreports.com.

About the American Microcap Institute
The American Microcap Institute (AMI), a subsidiary of Hawk Associates, is dedicated to providing investors with timely and accurate information on companies trading under $10. The AMI website provides investors with a free stock watch list and information about featured microcaps, company headlines, 20-minute-delayed Level II price quotes, e-mail alerts, CEO interviews and research reports. No registration is required to access the site. For more information, visit http://www.americanmicrocaps.com and http://www.amistockreports.com.

About Hawk Associates Inc.
Hawk Associates, Inc. is a full-service national investor relations and financial media relations consulting firm serving clients nationwide as well as in China and Vietnam. Hawk Associates operates the American Microcap Institute website, http://www.americanmicrocaps.com. For more information about Hawk Associates, visit http://www.hawkassociates.com or contact Frank Hawkins or Julie Marshall at (305) 451-1888, e-mail: mailto:info@hawkassociates.com.

About NeoGenomics, Inc.
NeoGenomics, Inc. is a high-complexity CLIA–certified clinical laboratory that offers cancer genetic diagnostic testing services including cytogenetics, fluorescence in-situ hybridization (FISH), flow cytometry and molecular genetic testing. NeoGenomics is headquartered in Fort Myers, Fla., and services the needs of oncologists, pathologists, urologists, hospitals and other reference laboratories not offering genetic testing throughout the United States. For additional information about NeoGenomics, visit http://www.neogenomics.org. An investment profile about NeoGenomics may be found online at http://www.hawkassociates.com/ngnmprofile.aspx. Interested parties can also access in-depth equity research from the American Microcap Institute at http://www.americanmicrocaps.com/ngnm. An online investor kit including press releases, current price quotes, stock charts and other valuable information for investors may be found at http://www.hawkassociates.com and http://www.americanmicrocaps.com. For investor relations questions regarding NeoGenomics, contact Frank Hawkins or Julie Marshall, Hawk Associates, at (305) 451-1888, e-mail: info@hawkassociates.com.